Together, these results suggest that MGMT protein can be expressed in a substantial fraction of MGMT promoter-methylated colorectal cancer, and low MGMT expression in tumor cells and increased local effector TILs were associated with benefit from TMZ and olaparib. The gene discussed is MGMT; the disease is neoplasm.